Showing results (2211-2220 of 6,689) with videos related to

Sort By:
Pageof 669
Neurobiology of Disease|March 21, 2022
Gut dysbiosis and age-related neurological diseases in femalesJanelle M Korf, Bhanu P Ganesh, Louise D McCullough
Neurobiology of Disease|March 22, 2022
Inflammation in dementia with Lewy bodiesJay Amin, Daniel Erskine, Paul C Donaghy, et al.
Neurobiology of Disease|March 4, 2022
Dopaminergic modulation of primary motor cortex: From cellular and synaptic mechanisms underlying motor learning to cognitive symptoms in Parkinson's diseaseJérémy Cousineau, Valentin Plateau, Jérôme Baufreton, et al.
Neurobiology of Disease|October 21, 1999
PMP22 accumulation in aggresomes: implications for CMT1A pathologyL Notterpek, M C Ryan, A R Tobler, et al.
Neurobiology of Disease|May 27, 1999
Upregulation of the aromatic amino acid decarboxylase under neonatal asphyxiaP Brust, R Bauer, G Vorwieger, et al.
Neurobiology of Disease|May 27, 1999
Differential expression of group I metabotropic glutamate receptors in rat spinal cord somatic and autonomic motoneurons: possible implications for the pathogenesis of amyotrophic lateral sclerosisJ M Anneser, G D Borasio, A Berthele, et al.
Neurobiology of Disease|August 17, 1999
Amyloid phenotype characterization of transgenic mice overexpressing both mutant amyloid precursor protein and mutant presenilin 1 transgenesE McGowan, S Sanders, T Iwatsubo, et al.
Neurobiology of Disease|August 17, 1999
Evidence that Abeta42 plasma levels in presenilin-1 mutation carriers do not allow for prediction of their clinical phenotypeC De Jonghe, P Cras, H Vanderstichele, et al.
Neurobiology of Disease|August 17, 1999
CTG18.1 and ERDA-1 CAG/CTG repeat size in bipolar disorderC A Guy, T Bowen, I Jones, et al.
Neurobiology of Disease|July 17, 1999
Reduction of ischemic damage in NGF-transgenic mice: correlation with enhancement of antioxidant enzyme activitiesC Guégan, I Ceballos-Picot, E Chevalier, et al.
Pageof 669